Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 443.00 | |
100 mg | In stock | $ 639.00 | |
500 mg | In stock | $ 1,330.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 109.00 |
Description | Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II. |
Targets&IC50 | CA II (human):0.18 μM |
In vivo | Compound CDy9 (100 μ M; 24-48 hours) exhibits no cytotoxicity to HEK-293 T cells, with cell viability>90% (versus control) [1]. |
Molecular Weight | 336.36 |
Formula | C15H16N2O5S |
CAS No. | 952306-80-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (81.76 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Compound CDy9 952306-80-8 Metabolism Carbonic Anhydrase CompoundCDy9 inhibitor inhibit